Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMITAL for Chemoradiation-Induced Mucositis in Head and Neck Cancer
NCT01674374Phase 2Withdrawn
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- May 2013
- Primary completion
- Jul 2015
01
Overview
A Phase 2 trial of Samital in mucositis, sponsored by Roswell Park Comprehensive Cancer Center. Planned start May 2013; status: withdrawn.
02
Drugs
Samital
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT01674374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01674374.